相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complications of Proton Pump Inhibitor Therapy
Michael F. Vaezi et al.
GASTROENTEROLOGY (2017)
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors
J. L. Schneider et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
Proton pump inhibitors alter the composition of the gut microbiota
Matthew A. Jackson et al.
GUT (2016)
Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
Xiaoyu Zeng et al.
ONCOTARGET (2016)
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Benjamin Lazarus et al.
JAMA INTERNAL MEDICINE (2016)
Increased Risk of Microscopic Colitis With Use of Proton Pump Inhibitors and Non-Steroidal Anti-Inflammatory Drugs
Gwen M. C. Masclee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Elizabeth D. Kantor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Risk of dementia in elderly patients with the use of proton pump inhibitors
Britta Haenisch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Wai-Kit Lo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers
Adetunji T. Toriola et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
Sailajah Janarthanan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Obesity-Driven Inflammation and Colorectal Cancer
N. Vazzana et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2010)
Critical roles of T-LAK cell-originated protein kinase in cytokinesis
Jae-Hyun Park et al.
CANCER SCIENCE (2010)
Primary Prevention of Colorectal Cancer
Andrew T. Chan et al.
GASTROENTEROLOGY (2010)
Long-Term Use of Statins and Risk of Colorectal Cancer: A Population-Based Study
Harminder Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH
Julia Kirchheiner et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Colorectal cancer risk in relation to use of acid suppressive medications
Jessica Chubak et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Proton pump inhibitors and the risk of colorectal cancer
Eva M. van Soest et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
Yu-Xiao Yang et al.
GASTROENTEROLOGY (2007)
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT1 16 colorectal cancer cells
Feng Zhu et al.
GASTROENTEROLOGY (2007)
Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
Douglas J. Robertson et al.
GASTROENTEROLOGY (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities
XQ Li et al.
DRUG METABOLISM AND DISPOSITION (2004)
Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa
EC Klinkenberg-Knol et al.
GASTROENTEROLOGY (2000)
分享论文
